Answer:
stock price will not change at all
Explanation:
Based on the information provided it can be said that when the company releases its next earnings report the stock price will not change at all. This is because stock markets move fast, the stock price of EPS moved when the in the announcement about FDA approval was made. Therefore the markets already expect these changes to reflect on the earnings report so prices will not move. Just as the saying goes, "Buy the Rumor, Sell the news."
The given statement " A director violates the corporate opportunity doctrine if he or she competes with the corporation, unless the disinterested directors approve of the director's actions " is TRUE
Explanation:
A business opportunity applies to any business opportunity that a client may gain.
The Corporate Opportunity law controls the moral responsibility of directors, managers and managing stockholders in an organisation, with loyalty responsibilities, not to misuse such incentives without first offering to the corporate board the right to reject the opportunity on behalf of the company.
When these actions are broken and a director of the company takes the chance, then the trustee has abused his obligation to be trustworthy and will be able to maintain a constructive trust with the proceeds arising from the incorrect transaction.
False !! it will be low in low season !!
j jl Ulrich upvpici jl ljc
Answer:
Debit finished goods inventory
Credit Work in Process Inventory
Explanation:
The journal entry that is required to transfer the completed products from the production stage to finished goods inventory which is the amount of goods in the inventory that have been produced and as well is available and ready for customer to buy will includes to Debit finished goods inventory and to Credit Work in Process. Inventory
Debit finished goods inventory
Credit Work in Process Inventory
(Being to record finished goods inventory)
